Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
$IKT MomentumIts trading | conix | investorshub | 04/19/2023 2:44:58 PM |
$IKT Time for this to show some returns | jedijazz | investorshub | 04/19/2023 11:17:44 AM |
$IKT Price now | ProfitScout | investorshub | 04/19/2023 9:06:23 AM |
$IKT Do we have a winner?Turn around time? | conix | investorshub | 04/19/2023 1:57:33 AM |
Do we have a winner?Turn around time? | conix | investorshub | 04/19/2023 12:04:40 AM |
MomentumIts trading | estreet7883 | investorshub | 04/18/2023 9:58:52 PM |
what does this mean? | conix | investorshub | 04/18/2023 6:02:20 PM |
MomentumIts gaining | conix | investorshub | 04/18/2023 1:42:42 PM |
$IKT Good news recently, we should start to see this one move | conix | investorshub | 04/18/2023 1:18:38 PM |
MomentumIts now last trade up | conix | investorshub | 04/18/2023 1:00:17 PM |
Price trading | ProfitScout | investorshub | 04/18/2023 10:58:08 AM |
Move$ | CarlCarlMcB | investorshub | 04/18/2023 10:31:04 AM |
is it bear time? Or do we go bull? | ProfitScout | investorshub | 04/18/2023 8:00:46 AM |
Price gaining last trade up | conix | investorshub | 04/18/2023 3:09:42 AM |
The now | ProfitScout | investorshub | 04/17/2023 6:41:43 PM |
$IKT Price trading last up | conix | investorshub | 04/17/2023 6:18:04 PM |
$IKT Time for this to show some returns | conix | investorshub | 04/17/2023 6:06:14 PM |
great news | kzivann | investorshub | 04/17/2023 11:49:02 AM |
$IKT Price gaining | PennyPusher786 | investorshub | 04/17/2023 9:44:32 AM |
$IKT Found an interesting article | jedijazz | investorshub | 04/17/2023 8:00:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...
BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...
- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or ...